FDA Drug Application (021729) for ABILIFY by OTSUKA

Back to FDA Applications sponsored by OTSUKA

Application Number021729
Product Number002
FormTABLET, ORALLY DISINTEGRATING;ORAL
Dosage10MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameABILIFY
Active IngredientARIPIPRAZOLE

Active IngredientCount
List of drugs with Active Ingredient ARIPIPRAZOLE3


Back to FDA Applications sponsored by OTSUKA